Abstract:Young women with anorexia nervosa (AN) have subnormal levels of dehydroepiandrosterone (DHEA) and estrogen that may be mechanistically linked to the bone loss seen in this disease. The purpose of this study was to compare the effects of a 1-yr course of oral DHEA treatment vs. conventional hormonal replacement therapy (HRT) in young women with AN. Sixty-one young women were randomly assigned to receive oral DHEA (50 mg/d) or HRT (20 micro g ethinyl estradiol/0.1 mg levonorgestrel). Anthropometric, nutrition, and exercise data were acquired every 3 months, and bone mineral density (BMD) and body composition were measured by dual energy x-ray absorptiometry (DXA) every 6 months over 1 yr. Serum samples were obtained for measurements of hormones, proresorptive cytokines, and bone formation markers, and urine was collected for determinations of bone resorption markers at each visit. In initial analyses, total hip BMD increased significantly and similarly (+1.7%) in both groups. Hip BMD increases were positively correlated with increases in IGF-I (r = 0.44; P = 0.030) and the bone formation marker, bone-specific alkaline phosphatase increased significantly only in the DHEA treatment group (P = 0.003). However, both groups gained significant amounts of weight over the year of therapy, and after controlling for weight gain, no treatment effect was detectable. There was no significant change in lumbar BMD in either group. Both bone formation markers, bone-specific alkaline phosphatase and osteocalcin, increased transiently at 6-9 months in those subjects receiving DHEA compared with the estrogen-treated group (P < 0.05). Both DHEA and HRT significantly reduced levels of the bone resorption markers, urinary N-telopeptides (P < 0.05). There was a positive correlation between changes in IGF-I and changes in weight, body fat determined by DXA, and estradiol for both groups. In addition, patients receiving DHEA exhibited improvement on three validated psychological instruments (Eating Attitudes Test, Anorexia Nervosa Subtest, and Spielberger Anxiety Inventory). Both DHEA and HRT had similar effects on hip and spinal BMD. Over the year of treatment, maintenance of both hip and spinal BMD was seen, but there was no significant increase after accounting for weight gain. Compared with HRT, DHEA appeared to have anabolic effects, evidenced by the positive correlation between increases in hip DXA measurements and IGF-I and significant increases in bone formation markers. Both therapies significantly decreased bone resorption. Replicating results from studies of the elderly, DHEA resulted in improvements in specific psychological parameters in these young women.

Prevalence and Predictive Factors for Regional Osteopenia in Women with Anorexia Nervosa

Anorexia Nervosa and Osteoporosis

Anorexia Nervosa and Osteoporosis: Pathophysiology and Treatment

Utility of anthropometric indicators in predicting osteoporosis in ambulant community dwelling rural postmenopausal women from southern India

The impact of reproductive and menstrual history on bone mineral density in Chinese women.

Risk of Subsequent Fractures and Mortality in Elderly Women and Men with Fragility Fractures with and without Osteoporotic Bone Density: The Dubbo Osteoporosis Epidemiology Study

Bone metabolism markers in adolescent girls with eating disorders and weight loss: effects of growth, weight trend, developmental and menstrual status

Identification of the Risk Factors Associated with Low Bone Density in Peri- and Early Postmenopausal Women

Effects of denosumab on osteoporosis in three cases with anorexia nervosa and a review of the literature

Perspective how many women have osteoporosis?

Factors Associated with Appendicular Bone Mass in Older Women

Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women

Age-related Bone Mineral Density, Bone Loss Rate, Prevalence of Osteoporosis and Reference Database of Women at Multiple Centers in China

Prevalence and risk factors of osteopenia and osteoporosis among postmenopausal women: A cross-sectional study from Jordan

Adult Premenopausal Bone Health Related to Reproductive Characteristics-Population-Based Data from the Canadian Multicentre Osteoporosis Study (CaM os)

Spinal osteoarthritis is a risk of vertebral fractures in postmenopausal women

Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial

Plasma Low-Density Lipoprotein Cholesterol and Bone Mass Densitometry in Postmenopausal Women

Reduced Prealbumin is Associated with Bone Mineral Density in Women with Osteoporosis.

The relationship of body composition with bone mineral density and 10-year probability of hip fracture in postmenopausal women

Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors